1. Monoclonal antibody against human ovarian tumor-associated antigens;Poels, L.G.; Peters, D.; van Megen, Y.; Vooijs, P.G.; Veheijen, R.H.M.; Willemen, A.;Nad Cancer Inst,1986
2. Characterization of human ovarian carcinoma associated antigens defined by novel monoclonal antibodies with tumor restricted specificity;Miotti, S.; Canevari, S.; Menard, D.; Mezzanzanica, D.; Porro, G.; Pupa, S.M.;Int Jf Cancer,1987
3. Immunoscintigraphy of ovarian cancer with indium-l l labeled OV-TL 3 (Fab')2 monoclonal antibody;Massuger, L.F.A.G.; Kenemans, P.; Claessens, R.A.M.J.; Verheijen, R.H.M.; Schijf, C.P.T.; Strijk, S.P.;Nucd Med,1990
4. Radioimmunoscintigraphy of ovarian cancerwith;Crippa, F.; Buraggi, G.L.; Di Re, E.; Gasparini, M.; Seregni, E.; Canevari, S.,1991
5. Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes. A multicentre study;Bolhuis, R.L.H.; Lamers, C.H.J.; Goey, S.H.; Eggermont, A.M.M.; Trimbos, J.B.; Stoter, G.;IntJ Cancer,1992